Cargando…
Apelin as a new therapeutic target for COVID-19 treatment
BACKGROUND: Apelin is an endogenous neuropeptide that binds to the G-protein-coupled receptor (APJ) and participates in a variety of physiological processes in the heart, lungs and other peripheral organs. Intriguingly, [Pyr1]-Apelin-13, a highly potent pyroglutamic form of apelin, has the potential...
Autores principales: | Park, J, Park, M -Y, Kim, Y, Jun, Y, Lee, U, Oh, C -M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619586/ https://www.ncbi.nlm.nih.gov/pubmed/36200913 http://dx.doi.org/10.1093/qjmed/hcac229 |
Ejemplares similares
-
Targeting the elabela/apelin-apelin receptor axis as a novel therapeutic approach for hypertension
por: Song, Jiawei, et al.
Publicado: (2022) -
Apelin protects against abdominal aortic aneurysm and the therapeutic role of neutral endopeptidase resistant apelin analogs
por: Wang, Wang, et al.
Publicado: (2019) -
Loss of Apelin Exacerbates Myocardial Infarction Adverse Remodeling and Ischemia‐reperfusion Injury: Therapeutic Potential of Synthetic Apelin Analogues
por: Wang, Wang, et al.
Publicado: (2013) -
Temporal Expression of Apelin/Apelin Receptor in Ischemic Stroke and its Therapeutic Potential
por: Wu, Yili, et al.
Publicado: (2017) -
Apelin/APJ system: an emerging therapeutic target for neurological diseases
por: Li, Ao, et al.
Publicado: (2022)